 WIXOM, Mich., Sept. 09, 2021 GLOBE NEWSWIRE -- Rockwell Medical, Inc. Nasdaq: RMTI, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that members of its executive management team are scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference, being held virtually September 13-15, 2021. 